goetzpartners advised NORD Holding

goetzpartners advised NORD Holding and its portfolio company Zentrum Gesundheit with a Commercial Due Diligence ("CDD") and Debt Advisory services on the acquisition of REALEYES, a leading ophthalmology platform headquartered in Munich with a comprehensive treatment portfolio spanning from medical surgeries over refractive surgeries for eye vision correction to a broad range of conservative treatments.

Within a competitive process, goetzpartners could apply its strength towards a competitive edge during the whole process by making use of its integrated service offering. Through the combination of our dedicated Private Equity Consulting practice, with plenty of expertise in the German healthcare and ophthalmology market, as well as our Debt Advisory experts, we were able to provide a bankable Commercial Due Diligence report early on, taking into account the information requirements of our client and potential lenders. The CDD was tailored to the specific investment opportunity with analyses covering the company's medical staff structure, capabilities and reputation of surgeons, branch-by-branch financial performance, and a differentiated view on COVID-19-related effects on a per-treatment basis. The Debt Advisory team managed the competitive lender due diligence process with various potential financing structures, advised during the term sheet and credit contract negotiations, and ensured a swift financing process to achieve best market terms within a tight deadline. During the whole due diligence and Q&A process, the seamless and established collaboration of both teams ensured both, a smooth and fast-paced process as well as maximum transaction security.

The project is another successful example for goetzpartners’ unique service portfolio combining transaction-related services incl. Commercial Due Diligence, Debt Advisory, and M&A in the interest of its clients. For NORD Holding's Zentrum Gesundheit Group this transaction constitutes the eighth add-on investment in 2021.

About REALEYES
Founded in Germany in 2000 and headquartered in Munich, REALEYES is a market leader among premium providers of ophthalmology services with 126 employees at 21 sites. The network's comprehensive treatment portfolio spans from medical surgeries, especially comprising cataract and IVOM treatments, over refractive surgeries for eye vision correction to a broad range of other surgeries and conservative treatments.

About NORD Holding
With a more than 50-year history and assets under management of € 2.5 billion NORD Holding is one of the leading private equity asset management companies in Germany. The business consists of the Direct Investments and the Fund Investments divisions.

Transaction Team:

Commercial Due Diligence

Dr. Gerrit Schütte
Managing Director

Alexander Reitmann
Manager

Linh Dong
Consultant

Dominik Wenzel
Consultant

Debt Advisory

Philipp Widmaier
Managing Director

Marius Wolter
Associate Director